INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 8 2024 08:00:04 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08 8 2024 08:00:26 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

07 8 2024 07:40:54 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

07 8 2024 07:30:38 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

24 7 2024 08:00:01 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

18 6 2024 07:30:16 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10 6 2024 08:00:34 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

29 5 2024 08:00:54 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

23 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

08 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

07 5 2024 07:30:00 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

30 4 2024 08:00:53 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

24 4 2024 16:01:19 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Prices Public Offering of Common Stock

17 4 2024 20:46:08 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

16 4 2024 16:06:34 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

16 4 2024 09:45:25 提供 NetDania Notify

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

16 4 2024 07:00:53 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

28 3 2024 09:47:48 提供 NetDania Notify

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

19 3 2024 08:30:38 提供 Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

06 3 2024 08:00:20 提供 Nasdaq GlobeNewswire